|
30.03.2010: Carboplatin and paclitaxel versus cisplatin, paclitaxel and doxorubicin for first-line chemotherapy of advanced ovarian cancer a Hellenic Cooperative Oncology Group (HeCOG) study
“Carboplatin and paclitaxel versus cisplatin, paclitaxel and doxorubicin for first-line chemotherapy of advanced ovarian cancer a Hellenic Cooperative Oncology Group (HeCOG) study” Eur J Cancer. 2008 Oct; 44(15):2169-77, Aravantinos G, Fountzilas G, Bamias A, Grimani I, Rizos S, Kalofonos HP, Skarlos D, Economopoulos T, Kosmidis P, Stathopoulos G, Briasoulis E, Pectasides D, Samantas E, Timotheadou E, Papadimitriou C, Papanikolaou A, Onyenadum A, Papakostas P, Bafaloukos D, Dimopoulos M; Hellenic Cooperative Oncology Group study
|